Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

Journal of Steroid Biochemistry

Volumn 34, Issue 1-6, 1989, Pages 123-131

  Harris, Adrian L ^a   Nicholson, Stewart ^b   Richard, J ^c   Sainsbury, C ^b   Farndon, John ^b   Wright, Chris ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Departments of Pathology University of Newcastle upon Tyne ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HYDROCORTISONE; TAMOXIFEN;

BREAST CANCER; CONFERENCE PAPER; DEATH; FATALITY; HORMONE RESPONSE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; SURVIVAL;

ADULT; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMAN; LYMPHATIC METASTASIS; MIDDLE AGE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 0024822342     PISSN: 00224731     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-4731(89)90072-1     Document Type: Article

References (43)

1. Epidermal growth factor A
2. A native 170,000 epidermal growth factor receptor- kinase complex from shed plasma membrane vesicles
3. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences
4. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines
5. Characterization of estrogen responsive transforming activity in human breast cancer cell lines
6. Transforming growth factors produced by certain human tumour cells: polypeptides that interact with epidermal growth factor receptors
7. Authocrine and paracrine growth regulation of human breast cancer
8. Epidermal growth factor binding by breast tumour biopsies and relationship to oestrogen receptor and progestin receptor levels
9. Epidermal growth factor receptors in human breast cancer
10. Epidermal growth factor receptors and oestrogen receptors in human breast cancer
11. Receptors for epidermal growth factor in human mammary carcinomas and their metastases
12. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance
13. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer
14. Epidermal growth factor receptor status as predictor of early recurrence of, and death from, breast cancer
15. r tumor antigen
16. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
17. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity
18. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor
19. The neu gene: an erbB-homologous gene distinct from the unliked to the gene encoding the EGF receptor
20. A v-erbB related proto-oncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
21. Amplification of a novel v-erbB-related gene in a human mammary carcinoma
22. Amplification of c-erbB oncogene in human adenocarcinomas in vivo
23. Sporadic amplification of the HER2/neu proto-oncogene in adenocarcinomas of various tissues
24. Over expression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistologic assessment correlates with gene amplification
25. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with node status and nuclear grading
26. Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncogene
27. r 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor receptors stimulated KB cells is the product of c-erbB-2 gene
28. Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells
29. Steroid-hormone receptors and survival after first relapse in breast cancer
30. Estrophilin assays in breast cancer: quantitative features and application the mastectomy specimen
31. New storage procedure for human tumour biopsies prior to oestrogen receptor measurement
32. Assessment of response to therapy in advanced breast cancer
33. Antihormone treatment of stage IV breast cancer
34. Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
35. Treatment of primary breast cancer in the elderly with “Nolvadex” alone
36. Systemic therapy—prolonged survival or growth control?
37. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer
38. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples
39. Expression of the c-erbB-2 protein in normal and transformed cells
40. The Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer: clinicopathological aspects
41. Immunohistochemical localization of c-erbB-2 immunorectivity in benign and malignant breast disease
42. Inhibition of tumour growth by a monoclonal antibody reactive with an oncogene-encoded tumour antigen
43. Neu protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in Stage II breast cancer